- Home
- SOC vs BHC Comparison
SOC vs BHC Comparison
Compare SOC & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOC | BHC |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | Canada |
| Employees | 200 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SOC | BHC |
|---|---|---|
| Price | $13.18 | $5.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $17.33 | $8.00 |
| AVG Volume (30 Days) | ★ 2.8M | 1.6M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | $73.55 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.72 | $4.41 |
| 52 Week High | $35.00 | $8.69 |
Technical Indicators
Market Signals| Indicator | SOC | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 45.15 |
| Support Level | $12.85 | $4.93 |
| Resistance Level | $13.31 | $5.62 |
| Average True Range (ATR) | 0.88 | 0.24 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 38.21 | 10.44 |
Price Performance
Historical ComparisonAbout SOC Sable Offshore Corp.
Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.